Medical Imaging AI Market Size, Share & Trends Analysis Report by Component (Software, Hardware, Services), Deployment Mode, Imaging Modality, Technology, Workflow Stage, Functionality, Clinical Setting, Application, End User and Geography (North America, Europe, Asia Pacific, Middle East, Africa, and South America) – Global Industry Data, Trends, and Forecasts, 2025–2035
|
Market Structure & Evolution |
|
|
Segmental Data Insights |
|
|
Demand Trends |
|
|
Competitive Landscape |
|
|
Strategic Development |
|
|
Future Outlook & Opportunities |
|
Medical Imaging AI Market Size, Share, and Growth
The global medical imaging AI market is experiencing robust growth, with its estimated value of USD 0.8 billion in the year 2025 and USD 4.6 billion by 2035, registering a CAGR of 19.4% during the forecast period.
Elad Walach serving as the co-founder and Chief Executive Officer of Aidoc explained that AdventHealth provides patients with prompt and valuable imaging test results which guide their medical treatment process. The health systems will achieve their goals of using artificial intelligence when they work together to develop responsible solutions which enable them to use technology that matches their clinical knowledge for improved patient treatment delivery across multiple sites.
The global medical imaging AI market is expanding quickly because of advanced AI solutions which provide better diagnostic results and faster operational processes. For example, Samsung introduced its R20 ultrasound system with AI capabilities which improve image quality and optimize standard imaging operations in 2025.
The healthcare sector experiences faster growth rates because hospitals and diagnostic centers adopt new technologies which help detect diseases during their early stages while maintaining high accuracy levels. The implementation of regulatory approvals together with GE HealthCare's 2025 AI research expansion will enable organizations to establish clinical workflows and develop their operational processes.
The market expansion receives support from digital transformation activities together with organizations establishing AI algorithm partnerships and cloud/AI provider collaborations. The analysts predict major market growth because the tools will reduce time needed for understanding results while improving patient treatment results.
The market provides potential for growth in multiple areas which include AI‑assisted radiology reporting systems and cloud‑based imaging informatics platforms and predictive analytics for early disease detection and automated triage and workflow prioritization tools. Organizations in manufacturing and healthcare technology sectors can extend their operational capabilities through these related business areas.
Medical Imaging AI Market Dynamics and Trends
Driver: Increasing Demand and Regulatory Alignment Driving Adoption of AI in Medical Imaging
-
Healthcare systems need to enhance patient outcomes through their requirements for artificial intelligence implementation in medical imaging because diagnostic workloads have increased, and swift and accurate results are needed.
- The national healthcare standards and quality requirements which include radiology reporting standards and imaging turnaround time objectives drive healthcare providers to implement AI-assisted solutions which help them meet compliance requirements while enhancing clinical consistency. The Picture Archiving and Communication Systems (PACS) and electronic health record (EHR) interoperability projects facilitate better integration of regulatory workflows into their systems.
- The Rajalakshmi Advanced Diagnostics and Applied Radiomics Center (RADAR) Centre in Chennai established its advanced MRI facility with AI-based image analysis technology in May 2025 to support both precise diagnostic work and cross-disciplinary studies which show how emerging markets adopt new technologies.
- The industry experiences ongoing investment in medical imaging AI market because radiology faces workforce shortages which drive rising imaging demands and digital transformation policies receive government backing. All these factors are likely to continue to escalate the growth of the medical imaging AI market.
Restraint: Implementation Costs, Trust Barriers, and Integration Challenges
-
The implementation of AI imaging tools encounters major hurdles because their operational expenses exceed budget limits of small clinics and rural medical facilities despite the technology providing significant clinical advantages. The expenses for implementation increase because the organization requires all systems to enhance their capabilities for secure data handling and storage solutions and connectivity options.
- A major obstacle to development exists because doctors lack confidence in AI results which stems from their doubts about how algorithms function and how well they can be applied to new situations and how AI systems will handle errors when they receive no input from a doctor. The process of getting regulatory approvals and model validation leads to slow market entry for AI systems which demand extensive testing and certification before they can be used in medical settings.
- The presence of outdated hospital IT systems and PACS systems creates difficulties for systems that need to connect with each other. All these elements are expected to restrict the expansion of the medical imaging AI market.
Opportunity: Specialty Imaging and Emerging Market Expansion
-
The specialty imaging fields of oncology, neurology, and cardiology now experience growing opportunities because AI technologies help with early disease detection and prognostic modeling and image quantification. AI‑enhanced imaging in these areas has shown measurable improvements in diagnostic accuracy compared with manual review.
- The development of cloud-based imaging platforms and teleradiology services together with remote interpretation systems has made advanced AI technology available to healthcare providers in underserved regions, which creates new business opportunities for vendors and healthcare organizations.
- The partnership between imaging technology companies and cloud service providers together with regional health systems creates new growth opportunities in Asia Pacific and Latin America and Africa, which are currently developing their healthcare systems through increased diagnostic infrastructure development. And thus, is expected to create more opportunities in future for medical imaging AI market.
Key Trend: Integration of Advanced AI Techniques, Explainability, and Workflow Augmentation
-
The medical imaging AI market currently emphasizes advanced deep learning technologies together with generative models and explainable AI (XAI) to enhance diagnostic accuracy while building trust among clinicians. Vision transformers and multi‑modal models provide enhanced capabilities to extract features and detect patterns throughout different imaging techniques.
- AI expanded its applications by providing detection capabilities together with workflow support for radiologists through automated measurement tools and triage systems which produce structured reports while decreasing administrative tasks to boost productivity without replacing human skills.
- Medical imaging technology progresses through the development of AI systems that can connect to existing hospital systems which include PACS and EHR while delivering federated learning and secure analytics capabilities for hospitals to use their systems and develop better models over time. Therefore, is expected to influence significant trends in the medical imaging AI market.
Medical Imaging AI Market Analysis and Segmental Data
Deep Learning Dominates Global Medical Imaging AI Market Amid Rising Diagnostic Workloads and AI Adoption
-
Deep learning leads the medical imaging AI market because it learns complex features from large imaging datasets which enables accurate lesion detection and classification and segmentation tasks that radiologists use in their work.
- The technology accelerates diagnostic procedures while managing increasing medical imaging demands which results in more hospitals using it compared to different AI solutions. The system demonstrates its clinical value through its obtained regulatory approvals and its expanding collection of FDA-endorsed medical devices.
- The recent study demonstrated that deep learning algorithms including the uAI-Chest-Care platform can achieve excellent results for pulmonary nodule assessment based on CT scans which shows how deep learning technology improves medical diagnostic accuracy in actual healthcare environments. Thus, making deep learning the leading segment within medical imaging AI market.
North America Dominates Medical Imaging AI Market Amid Advanced Healthcare Infrastructure and Early AI Adoption
-
North America leads the global medical imaging AI market because its healthcare system uses advanced technology and digital imaging technology and has strong research and product development capabilities. The region benefits from widespread clinical adoption of AI tools, over half of U.S. radiology departments now routinely use AI to support workflows and improve diagnostic accuracy.
- The deployment of AI-enabled devices in hospitals and diagnostic centers receives support from regulatory incentives which include attractive reimbursement policies and fast clearance procedures.
- A recent U.S. example is the rollout of the AI‑driven Clairity Breast tool at Beth Israel Deaconess Medical Center, which uses FDA‑authorized AI models to enhance early breast cancer risk assessment, thereby confirming North America's leadership in global medical imaging AI market.
Medical Imaging AI Market Ecosystem
The medical imaging AI market shows moderate consolidation because major companies such as GE Healthcare and Siemens Healthineers and Philips and IBM Watson Health and Fujifilm hold significant market share.
The value chain of the business requires development of AI algorithms together with their validation and subsequent embedding into imaging processes. GE recently acquired MIM Software to enhance its analytic and workflow capabilities which demonstrates the company's strategic consolidation efforts and ecosystem development.
Recent Development and Strategic Overview:
-
In June 2025, Siemens Healthineers expanded its AI-Rad Companion portfolio with new applications for MRI and CT imaging, enabling automated organ segmentation and quantitative analysis to support faster and more consistent clinical decision-making. The new system improves radiology operations because it boosts efficiency and increases correct diagnosis rates for multiple types of medical imaging.
- In April 2025, Viz.ai received expanded regulatory clearance for its AI-powered care coordination platform which enables hospitals to detect and assess critical medical conditions through real-time monitoring of stroke and pulmonary embolism cases. The system improves emergency medical response times because it generates automated alerts and enables staff members to communicate through their integrated system.
Report Scope
|
Attribute |
Detail |
|
Market Size in 2025 |
USD 0.8 Bn |
|
Market Forecast Value in 2035 |
USD 4.6 Bn |
|
Growth Rate (CAGR) |
19.4% |
|
Forecast Period |
2025 – 2035 |
|
Historical Data Available for |
2020 – 2024 |
|
Market Size Units |
USD Billion for Value |
|
Report Format |
Electronic (PDF) + Excel |
|
Regions and Countries Covered |
|||||
|
North America |
Europe |
Asia Pacific |
Middle East |
Africa |
South America |
|
|
|
|
|
|
|
Companies Covered |
|||||
|
|
|
|
|
|
Medical Imaging AI Market Segmentation and Highlights
|
Segment |
Sub-segment |
|
Medical Imaging AI Market, By Component |
|
|
Medical Imaging AI Market, By Deployment Mode |
|
|
Medical Imaging AI Market, By Imaging Modality |
|
|
Medical Imaging AI Market, By Technology |
|
|
Medical Imaging AI Market, By Workflow Stage |
|
|
Medical Imaging AI Market, By Functionality |
|
|
Medical Imaging AI Market, By Clinical Setting |
|
|
Medical Imaging AI Market, By Application |
|
|
Medical Imaging AI Market, By End User |
|
Frequently Asked Questions
Table of Contents
- 1. Research Methodology and Assumptions
- 1.1. Definitions
- 1.2. Research Design and Approach
- 1.3. Data Collection Methods
- 1.4. Base Estimates and Calculations
- 1.5. Forecasting Models
- 1.5.1. Key Forecast Factors & Impact Analysis
- 1.6. Secondary Research
- 1.6.1. Open Natures
- 1.6.2. Paid Databases
- 1.6.3. Associations
- 1.7. Primary Research
- 1.7.1. Primary Natures
- 1.7.2. Primary Interviews with Stakeholders across Ecosystem
- 2. Executive Summary
- 2.1. Global Medical Imaging AI Market Outlook
- 2.1.1. Medical Imaging AI Market Size (Value - US$ Bn), and Forecasts, 2021-2035
- 2.1.2. Compounded Annual Growth Rate Analysis
- 2.1.3. Growth Opportunity Analysis
- 2.1.4. Segmental Share Analysis
- 2.1.5. Geographical Share Analysis
- 2.2. Market Analysis and Facts
- 2.3. Supply-Demand Analysis
- 2.4. Competitive Benchmarking
- 2.5. Go-to- Market Strategy
- 2.5.1. Customer/ End-use Industry Assessment
- 2.5.2. Growth Opportunity Data, 2026-2035
- 2.5.2.1. Regional Data
- 2.5.2.2. Country Data
- 2.5.2.3. Segmental Data
- 2.5.3. Identification of Potential Market Spaces
- 2.5.4. GAP Analysis
- 2.5.5. Potential Attractive Price Points
- 2.5.6. Prevailing Market Risks & Challenges
- 2.5.7. Preferred Sales & Marketing Strategies
- 2.5.8. Key Recommendations and Analysis
- 2.5.9. A Way Forward
- 2.1. Global Medical Imaging AI Market Outlook
- 3. Industry Data and Premium Insights
- 3.1. Global Healthcare & Pharmaceutical Industry Overview, 2025
- 3.1.1. Healthcare & Pharmaceutical Industry Analysis
- 3.1.2. Key Trends for Healthcare & Pharmaceutical Industry
- 3.1.3. Regional Distribution for Healthcare & Pharmaceutical Industry
- 3.2. Supplier Customer Data
- 3.3. Technology Roadmap and Developments
- 3.1. Global Healthcare & Pharmaceutical Industry Overview, 2025
- 4. Market Overview
- 4.1. Market Dynamics
- 4.1.1. Drivers
- 4.1.1.1. Rising imaging volumes and demand for faster, more accurate diagnostics are accelerating adoption of AI-enabled imaging solutions.
- 4.1.1.2. Advancements in deep learning and cloud-based platforms are enhancing image analysis, workflow efficiency, and clinical decision-making.
- 4.1.1.3. Increasing healthcare digitalization and supportive regulatory approvals are driving integration of AI into radiology practices.
- 4.1.2. Restraints
- 4.1.2.1. High implementation and integration costs limit adoption, especially among small and mid-sized healthcare providers.
- 4.1.2.2. Lack of trust in AI outputs and concerns over algorithm transparency hinder widespread clinical acceptance.
- 4.1.1. Drivers
- 4.2. Key Trend Analysis
- 4.3. Regulatory Framework
- 4.3.1. Key Regulations, Norms, and Subsidies, by Key Countries
- 4.3.2. Tariffs and Standards
- 4.3.3. Impact Analysis of Regulations on the Market
- 4.4. Value Chain Analysis
- 4.5. Porter’s Five Forces Analysis
- 4.6. PESTEL Analysis
- 4.7. Global Medical Imaging AI Market Demand
- 4.7.1. Historical Market Size – Value (US$ Bn), 2020-2024
- 4.7.2. Current and Future Market Size – Value (US$ Bn), 2026–2035
- 4.7.2.1. Y-o-Y Growth Trends
- 4.7.2.2. Absolute $ Opportunity Assessment
- 4.1. Market Dynamics
- 5. Competition Landscape
- 5.1. Competition structure
- 5.1.1. Fragmented v/s consolidated
- 5.2. Company Share Analysis, 2025
- 5.2.1. Global Company Market Share
- 5.2.2. By Region
- 5.2.2.1. North America
- 5.2.2.2. Europe
- 5.2.2.3. Asia Pacific
- 5.2.2.4. Middle East
- 5.2.2.5. Africa
- 5.2.2.6. South America
- 5.3. Product Comparison Matrix
- 5.3.1. Specifications
- 5.3.2. Market Positioning
- 5.3.3. Pricing
- 5.1. Competition structure
- 6. Global Medical Imaging AI Market Analysis, by Component
- 6.1. Key Segment Analysis
- 6.2. Medical Imaging AI Market Size (Value - US$ Bn), Analysis, and Forecasts, by Component, 2021-2035
- 6.2.1. Software
- 6.2.1.1. AI Algorithms & Models
- 6.2.1.1.1. Deep Learning Models
- 6.2.1.1.2. Machine Learning Models
- 6.2.1.1.3. Others
- 6.2.1.2. Image Analysis Software
- 6.2.1.2.1. Detection Software
- 6.2.1.2.2. Diagnosis Support Software
- 6.2.1.2.3. Segmentation & Quantification Tools
- 6.2.1.2.4. Others
- 6.2.1.3. Visualization & Reporting Software
- 6.2.1.3.1. 3D Visualization Tools
- 6.2.1.3.2. Automated Reporting Solutions
- 6.2.1.3.3. Others
- 6.2.1.4. Workflow Management Software
- 6.2.1.4.1. Triage & Prioritization Tools
- 6.2.1.4.2. PACS/RIS Integration Software
- 6.2.1.4.3. Others
- 6.2.1.5. Data Management Software
- 6.2.1.5.1. Image Data Platforms
- 6.2.1.5.2. Annotation Tools
- 6.2.1.5.3. Data Labeling Software
- 6.2.1.5.4. Others
- 6.2.1.1. AI Algorithms & Models
- 6.2.2. Hardware
- 6.2.2.1. Processing Units
- 6.2.2.1.1. GPUs (Graphics Processing Units)
- 6.2.2.1.2. CPUs (Central Processing Units)
- 6.2.2.1.3. Edge AI Processors
- 6.2.2.1.4. Others
- 6.2.2.2. Imaging Hardware Integration Components
- 6.2.2.2.1. AI-enabled CT Systems
- 6.2.2.2.2. AI-enabled MRI Systems
- 6.2.2.2.3. AI-enabled X-ray & Ultrasound Devices
- 6.2.2.2.4. Others
- 6.2.2.3. Storage Infrastructure
- 6.2.2.3.1. On-premise Servers
- 6.2.2.3.2. High-performance Storage Systems
- 6.2.2.3.3. Others
- 6.2.2.1. Processing Units
- 6.2.3. Services
- 6.2.3.1. Professional Services
- 6.2.3.1.1. Consulting Services
- 6.2.3.1.2. Integration & Deployment Services
- 6.2.3.1.3. Training & Education
- 6.2.3.1.4. Others
- 6.2.3.2. Support & Maintenance Services
- 6.2.3.2.1. Technical Support
- 6.2.3.2.2. Software Updates & Upgrades
- 6.2.3.2.3. Others
- 6.2.3.3. Managed Services
- 6.2.3.3.1. AI-as-a-Service (AIaaS)
- 6.2.3.3.2. Remote Monitoring & Management
- 6.2.3.3.3. Others
- 6.2.3.4. Data Services
- 6.2.3.4.1. Data Annotation & Labeling Services
- 6.2.3.4.2. Dataset Curation & Management
- 6.2.3.4.3. Others
- 6.2.3.1. Professional Services
- 6.2.1. Software
- 7. Global Medical Imaging AI Market Analysis, by Deployment Mode
- 7.1. Key Segment Analysis
- 7.2. Medical Imaging AI Market Size (Value - US$ Bn), Analysis, and Forecasts, by Deployment Mode, 2021-2035
- 7.2.1. Cloud-based
- 7.2.2. On-premises
- 7.2.3. Hybrid
- 8. Global Medical Imaging AI Market Analysis, by Imaging Modality
- 8.1. Key Segment Analysis
- 8.2. Medical Imaging AI Market Size (Value - US$ Bn), Analysis, and Forecasts, by Imaging Modality, 2021-2035
- 8.2.1. Computed Tomography (CT)
- 8.2.2. Magnetic Resonance Imaging (MRI)
- 8.2.3. X-ray
- 8.2.4. Ultrasound
- 8.2.5. Nuclear Imaging (PET/SPECT)
- 8.2.6. Mammography
- 8.2.7. Others
- 9. Global Medical Imaging AI Market Analysis, by Technology
- 9.1. Key Segment Analysis
- 9.2. Medical Imaging AI Market Size (Value - US$ Bn), Analysis, and Forecasts, by Technology, 2021-2035
- 9.2.1. Machine Learning
- 9.2.2. Deep Learning
- 9.2.3. Natural Language Processing (NLP)
- 9.2.4. Computer Vision
- 9.2.5. Others
- 10. Global Medical Imaging AI Market Analysis, by Workflow Stage
- 10.1. Key Segment Analysis
- 10.2. Medical Imaging AI Market Size (Value - US$ Bn), Analysis, and Forecasts, by Workflow Stage, 2021-2035
- 10.2.1. Image Acquisition
- 10.2.2. Image Processing & Analysis
- 10.2.3. Reporting & Communication
- 10.2.4. Data Storage & Management
- 10.2.5. Others
- 11. Global Medical Imaging AI Market Analysis, by Functionality
- 11.1. Key Segment Analysis
- 11.2. Medical Imaging AI Market Size (Value - US$ Bn), Analysis, and Forecasts, by Functionality, 2021-2035
- 11.2.1. Computer-Aided Detection (CADe)
- 11.2.2. Computer-Aided Diagnosis (CADx)
- 11.2.3. Image Quantification & Measurement
- 11.2.4. Workflow Optimization & Triage
- 11.2.5. Predictive Analytics
- 11.2.6. Others
- 12. Global Medical Imaging AI Market Analysis, by Clinical Setting
- 12.1. Key Segment Analysis
- 12.2. Medical Imaging AI Market Size (Value - US$ Bn), Analysis, and Forecasts, by Clinical Setting, 2021-2035
- 12.2.1. Emergency Care
- 12.2.2. Routine Diagnostics
- 12.2.3. Screening Programs
- 12.2.4. Intensive Care Units (ICU)
- 12.2.5. Others
- 13. Global Medical Imaging AI Market Analysis, by Application
- 13.1. Key Segment Analysis
- 13.2. Medical Imaging AI Market Size (Value - US$ Bn), Analysis, and Forecasts, by Application, 2021-2035
- 13.2.1. Neurology
- 13.2.2. Cardiology
- 13.2.3. Oncology
- 13.2.4. Orthopedics
- 13.2.5. Pulmonology
- 13.2.6. Breast Imaging
- 13.2.7. Gastroenterology
- 13.2.8. Others
- 14. Global Medical Imaging AI Market Analysis, by End User
- 14.1. Key Segment Analysis
- 14.2. Medical Imaging AI Market Size (Value - US$ Bn), Analysis, and Forecasts, by End User, 2021-2035
- 14.2.1. Hospitals
- 14.2.2. Diagnostic Imaging Centers
- 14.2.3. Ambulatory Surgical Centers
- 14.2.4. Research & Academic Institutes
- 14.2.5. Others
- 15. Global Medical Imaging AI Market Analysis and Forecasts, by Region
- 15.1. Key Findings
- 15.2. Medical Imaging AI Market Size (Value - US$ Bn), Analysis, and Forecasts, by Region, 2021-2035
- 15.2.1. North America
- 15.2.2. Europe
- 15.2.3. Asia Pacific
- 15.2.4. Middle East
- 15.2.5. Africa
- 15.2.6. South America
- 16. North America Medical Imaging AI Market Analysis
- 16.1. Key Segment Analysis
- 16.2. Regional Snapshot
- 16.3. North America Medical Imaging AI Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
- 16.3.1. Component
- 16.3.2. Deployment Mode
- 16.3.3. Imaging Modality
- 16.3.4. Technology
- 16.3.5. Workflow Stage
- 16.3.6. Functionality
- 16.3.7. Clinical Setting
- 16.3.8. Application
- 16.3.9. End User
- 16.3.10. Country
- 16.3.10.1. USA
- 16.3.10.2. Canada
- 16.3.10.3. Mexico
- 16.4. USA Medical Imaging AI Market
- 16.4.1. Country Segmental Analysis
- 16.4.2. Component
- 16.4.3. Deployment Mode
- 16.4.4. Imaging Modality
- 16.4.5. Technology
- 16.4.6. Workflow Stage
- 16.4.7. Functionality
- 16.4.8. Clinical Setting
- 16.4.9. Application
- 16.4.10. End User
- 16.5. Canada Medical Imaging AI Market
- 16.5.1. Country Segmental Analysis
- 16.5.2. Component
- 16.5.3. Deployment Mode
- 16.5.4. Imaging Modality
- 16.5.5. Technology
- 16.5.6. Workflow Stage
- 16.5.7. Functionality
- 16.5.8. Clinical Setting
- 16.5.9. Application
- 16.5.10. End User
- 16.6. Mexico Medical Imaging AI Market
- 16.6.1. Country Segmental Analysis
- 16.6.2. Component
- 16.6.3. Deployment Mode
- 16.6.4. Imaging Modality
- 16.6.5. Technology
- 16.6.6. Workflow Stage
- 16.6.7. Functionality
- 16.6.8. Clinical Setting
- 16.6.9. Application
- 16.6.10. End User
- 17. Europe Medical Imaging AI Market Analysis
- 17.1. Key Segment Analysis
- 17.2. Regional Snapshot
- 17.3. Europe Medical Imaging AI Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
- 17.3.1. Component
- 17.3.2. Deployment Mode
- 17.3.3. Imaging Modality
- 17.3.4. Technology
- 17.3.5. Workflow Stage
- 17.3.6. Functionality
- 17.3.7. Clinical Setting
- 17.3.8. Application
- 17.3.9. End User
- 17.3.10. Country
- 17.3.10.1. Germany
- 17.3.10.2. United Kingdom
- 17.3.10.3. France
- 17.3.10.4. Italy
- 17.3.10.5. Spain
- 17.3.10.6. Netherlands
- 17.3.10.7. Nordic Countries
- 17.3.10.8. Poland
- 17.3.10.9. Russia & CIS
- 17.3.10.10. Rest of Europe
- 17.4. Germany Medical Imaging AI Market
- 17.4.1. Country Segmental Analysis
- 17.4.2. Component
- 17.4.3. Deployment Mode
- 17.4.4. Imaging Modality
- 17.4.5. Technology
- 17.4.6. Workflow Stage
- 17.4.7. Functionality
- 17.4.8. Clinical Setting
- 17.4.9. Application
- 17.4.10. End User
- 17.5. United Kingdom Medical Imaging AI Market
- 17.5.1. Country Segmental Analysis
- 17.5.2. Component
- 17.5.3. Deployment Mode
- 17.5.4. Imaging Modality
- 17.5.5. Technology
- 17.5.6. Workflow Stage
- 17.5.7. Functionality
- 17.5.8. Clinical Setting
- 17.5.9. Application
- 17.5.10. End User
- 17.6. France Medical Imaging AI Market
- 17.6.1. Country Segmental Analysis
- 17.6.2. Component
- 17.6.3. Deployment Mode
- 17.6.4. Imaging Modality
- 17.6.5. Technology
- 17.6.6. Workflow Stage
- 17.6.7. Functionality
- 17.6.8. Clinical Setting
- 17.6.9. Application
- 17.6.10. End User
- 17.7. Italy Medical Imaging AI Market
- 17.7.1. Country Segmental Analysis
- 17.7.2. Component
- 17.7.3. Deployment Mode
- 17.7.4. Imaging Modality
- 17.7.5. Technology
- 17.7.6. Workflow Stage
- 17.7.7. Functionality
- 17.7.8. Clinical Setting
- 17.7.9. Application
- 17.7.10. End User
- 17.8. Spain Medical Imaging AI Market
- 17.8.1. Country Segmental Analysis
- 17.8.2. Component
- 17.8.3. Deployment Mode
- 17.8.4. Imaging Modality
- 17.8.5. Technology
- 17.8.6. Workflow Stage
- 17.8.7. Functionality
- 17.8.8. Clinical Setting
- 17.8.9. Application
- 17.8.10. End User
- 17.9. Netherlands Medical Imaging AI Market
- 17.9.1. Country Segmental Analysis
- 17.9.2. Component
- 17.9.3. Deployment Mode
- 17.9.4. Imaging Modality
- 17.9.5. Technology
- 17.9.6. Workflow Stage
- 17.9.7. Functionality
- 17.9.8. Clinical Setting
- 17.9.9. Application
- 17.9.10. End User
- 17.10. Nordic Countries Medical Imaging AI Market
- 17.10.1. Country Segmental Analysis
- 17.10.2. Component
- 17.10.3. Deployment Mode
- 17.10.4. Imaging Modality
- 17.10.5. Technology
- 17.10.6. Workflow Stage
- 17.10.7. Functionality
- 17.10.8. Clinical Setting
- 17.10.9. Application
- 17.10.10. End User
- 17.11. Poland Medical Imaging AI Market
- 17.11.1. Country Segmental Analysis
- 17.11.2. Component
- 17.11.3. Deployment Mode
- 17.11.4. Imaging Modality
- 17.11.5. Technology
- 17.11.6. Workflow Stage
- 17.11.7. Functionality
- 17.11.8. Clinical Setting
- 17.11.9. Application
- 17.11.10. End User
- 17.12. Russia & CIS Medical Imaging AI Market
- 17.12.1. Country Segmental Analysis
- 17.12.2. Component
- 17.12.3. Deployment Mode
- 17.12.4. Imaging Modality
- 17.12.5. Technology
- 17.12.6. Workflow Stage
- 17.12.7. Functionality
- 17.12.8. Clinical Setting
- 17.12.9. Application
- 17.12.10. End User
- 17.13. Rest of Europe Medical Imaging AI Market
- 17.13.1. Country Segmental Analysis
- 17.13.2. Component
- 17.13.3. Deployment Mode
- 17.13.4. Imaging Modality
- 17.13.5. Technology
- 17.13.6. Workflow Stage
- 17.13.7. Functionality
- 17.13.8. Clinical Setting
- 17.13.9. Application
- 17.13.10. End User
- 18. Asia Pacific Medical Imaging AI Market Analysis
- 18.1. Key Segment Analysis
- 18.2. Regional Snapshot
- 18.3. Asia Pacific Medical Imaging AI Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
- 18.3.1. Component
- 18.3.2. Deployment Mode
- 18.3.3. Imaging Modality
- 18.3.4. Technology
- 18.3.5. Workflow Stage
- 18.3.6. Functionality
- 18.3.7. Clinical Setting
- 18.3.8. Application
- 18.3.9. End User
- 18.3.10. Country
- 18.3.10.1. China
- 18.3.10.2. India
- 18.3.10.3. Japan
- 18.3.10.4. South Korea
- 18.3.10.5. Australia and New Zealand
- 18.3.10.6. Indonesia
- 18.3.10.7. Malaysia
- 18.3.10.8. Thailand
- 18.3.10.9. Vietnam
- 18.3.10.10. Rest of Asia Pacific
- 18.4. China Medical Imaging AI Market
- 18.4.1. Country Segmental Analysis
- 18.4.2. Component
- 18.4.3. Deployment Mode
- 18.4.4. Imaging Modality
- 18.4.5. Technology
- 18.4.6. Workflow Stage
- 18.4.7. Functionality
- 18.4.8. Clinical Setting
- 18.4.9. Application
- 18.4.10. End User
- 18.5. India Medical Imaging AI Market
- 18.5.1. Country Segmental Analysis
- 18.5.2. Component
- 18.5.3. Deployment Mode
- 18.5.4. Imaging Modality
- 18.5.5. Technology
- 18.5.6. Workflow Stage
- 18.5.7. Functionality
- 18.5.8. Clinical Setting
- 18.5.9. Application
- 18.5.10. End User
- 18.6. Japan Medical Imaging AI Market
- 18.6.1. Country Segmental Analysis
- 18.6.2. Component
- 18.6.3. Deployment Mode
- 18.6.4. Imaging Modality
- 18.6.5. Technology
- 18.6.6. Workflow Stage
- 18.6.7. Functionality
- 18.6.8. Clinical Setting
- 18.6.9. Application
- 18.6.10. End User
- 18.7. South Korea Medical Imaging AI Market
- 18.7.1. Country Segmental Analysis
- 18.7.2. Component
- 18.7.3. Deployment Mode
- 18.7.4. Imaging Modality
- 18.7.5. Technology
- 18.7.6. Workflow Stage
- 18.7.7. Functionality
- 18.7.8. Clinical Setting
- 18.7.9. Application
- 18.7.10. End User
- 18.8. Australia and New Zealand Medical Imaging AI Market
- 18.8.1. Country Segmental Analysis
- 18.8.2. Component
- 18.8.3. Deployment Mode
- 18.8.4. Imaging Modality
- 18.8.5. Technology
- 18.8.6. Workflow Stage
- 18.8.7. Functionality
- 18.8.8. Clinical Setting
- 18.8.9. Application
- 18.8.10. End User
- 18.9. Indonesia Medical Imaging AI Market
- 18.9.1. Country Segmental Analysis
- 18.9.2. Component
- 18.9.3. Deployment Mode
- 18.9.4. Imaging Modality
- 18.9.5. Technology
- 18.9.6. Workflow Stage
- 18.9.7. Functionality
- 18.9.8. Clinical Setting
- 18.9.9. Application
- 18.9.10. End User
- 18.10. Malaysia Medical Imaging AI Market
- 18.10.1. Country Segmental Analysis
- 18.10.2. Component
- 18.10.3. Deployment Mode
- 18.10.4. Imaging Modality
- 18.10.5. Technology
- 18.10.6. Workflow Stage
- 18.10.7. Functionality
- 18.10.8. Clinical Setting
- 18.10.9. Application
- 18.10.10. End User
- 18.11. Thailand Medical Imaging AI Market
- 18.11.1. Country Segmental Analysis
- 18.11.2. Component
- 18.11.3. Deployment Mode
- 18.11.4. Imaging Modality
- 18.11.5. Technology
- 18.11.6. Workflow Stage
- 18.11.7. Functionality
- 18.11.8. Clinical Setting
- 18.11.9. Application
- 18.11.10. End User
- 18.12. Vietnam Medical Imaging AI Market
- 18.12.1. Country Segmental Analysis
- 18.12.2. Component
- 18.12.3. Deployment Mode
- 18.12.4. Imaging Modality
- 18.12.5. Technology
- 18.12.6. Workflow Stage
- 18.12.7. Functionality
- 18.12.8. Clinical Setting
- 18.12.9. Application
- 18.12.10. End User
- 18.13. Rest of Asia Pacific Medical Imaging AI Market
- 18.13.1. Country Segmental Analysis
- 18.13.2. Component
- 18.13.3. Deployment Mode
- 18.13.4. Imaging Modality
- 18.13.5. Technology
- 18.13.6. Workflow Stage
- 18.13.7. Functionality
- 18.13.8. Clinical Setting
- 18.13.9. Application
- 18.13.10. End User
- 19. Middle East Medical Imaging AI Market Analysis
- 19.1. Key Segment Analysis
- 19.2. Regional Snapshot
- 19.3. Middle East Medical Imaging AI Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
- 19.3.1. Component
- 19.3.2. Deployment Mode
- 19.3.3. Imaging Modality
- 19.3.4. Technology
- 19.3.5. Workflow Stage
- 19.3.6. Functionality
- 19.3.7. Clinical Setting
- 19.3.8. Application
- 19.3.9. End User
- 19.3.10. Country
- 19.3.10.1. Turkey
- 19.3.10.2. UAE
- 19.3.10.3. Saudi Arabia
- 19.3.10.4. Israel
- 19.3.10.5. Rest of Middle East
- 19.4. Turkey Medical Imaging AI Market
- 19.4.1. Country Segmental Analysis
- 19.4.2. Component
- 19.4.3. Deployment Mode
- 19.4.4. Imaging Modality
- 19.4.5. Technology
- 19.4.6. Workflow Stage
- 19.4.7. Functionality
- 19.4.8. Clinical Setting
- 19.4.9. Application
- 19.4.10. End User
- 19.5. UAE Medical Imaging AI Market
- 19.5.1. Country Segmental Analysis
- 19.5.2. Component
- 19.5.3. Deployment Mode
- 19.5.4. Imaging Modality
- 19.5.5. Technology
- 19.5.6. Workflow Stage
- 19.5.7. Functionality
- 19.5.8. Clinical Setting
- 19.5.9. Application
- 19.5.10. End User
- 19.6. Saudi Arabia Medical Imaging AI Market
- 19.6.1. Country Segmental Analysis
- 19.6.2. Component
- 19.6.3. Deployment Mode
- 19.6.4. Imaging Modality
- 19.6.5. Technology
- 19.6.6. Workflow Stage
- 19.6.7. Functionality
- 19.6.8. Clinical Setting
- 19.6.9. Application
- 19.6.10. End User
- 19.7. Israel Medical Imaging AI Market
- 19.7.1. Country Segmental Analysis
- 19.7.2. Component
- 19.7.3. Deployment Mode
- 19.7.4. Imaging Modality
- 19.7.5. Technology
- 19.7.6. Workflow Stage
- 19.7.7. Functionality
- 19.7.8. Clinical Setting
- 19.7.9. Application
- 19.7.10. End User
- 19.8. Rest of Middle East Medical Imaging AI Market
- 19.8.1. Country Segmental Analysis
- 19.8.2. Component
- 19.8.3. Deployment Mode
- 19.8.4. Imaging Modality
- 19.8.5. Technology
- 19.8.6. Workflow Stage
- 19.8.7. Functionality
- 19.8.8. Clinical Setting
- 19.8.9. Application
- 19.8.10. End User
- 20. Africa Medical Imaging AI Market Analysis
- 20.1. Key Segment Analysis
- 20.2. Regional Snapshot
- 20.3. Africa Medical Imaging AI Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
- 20.3.1. Component
- 20.3.2. Deployment Mode
- 20.3.3. Imaging Modality
- 20.3.4. Technology
- 20.3.5. Workflow Stage
- 20.3.6. Functionality
- 20.3.7. Clinical Setting
- 20.3.8. Application
- 20.3.9. End User
- 20.3.10. Country
- 20.3.10.1. South Africa
- 20.3.10.2. Egypt
- 20.3.10.3. Nigeria
- 20.3.10.4. Algeria
- 20.3.10.5. Rest of Africa
- 20.4. South Africa Medical Imaging AI Market
- 20.4.1. Country Segmental Analysis
- 20.4.2. Component
- 20.4.3. Deployment Mode
- 20.4.4. Imaging Modality
- 20.4.5. Technology
- 20.4.6. Workflow Stage
- 20.4.7. Functionality
- 20.4.8. Clinical Setting
- 20.4.9. Application
- 20.4.10. End User
- 20.5. Egypt Medical Imaging AI Market
- 20.5.1. Country Segmental Analysis
- 20.5.2. Component
- 20.5.3. Deployment Mode
- 20.5.4. Imaging Modality
- 20.5.5. Technology
- 20.5.6. Workflow Stage
- 20.5.7. Functionality
- 20.5.8. Clinical Setting
- 20.5.9. Application
- 20.5.10. End User
- 20.6. Nigeria Medical Imaging AI Market
- 20.6.1. Country Segmental Analysis
- 20.6.2. Component
- 20.6.3. Deployment Mode
- 20.6.4. Imaging Modality
- 20.6.5. Technology
- 20.6.6. Workflow Stage
- 20.6.7. Functionality
- 20.6.8. Clinical Setting
- 20.6.9. Application
- 20.6.10. End User
- 20.7. Algeria Medical Imaging AI Market
- 20.7.1. Country Segmental Analysis
- 20.7.2. Component
- 20.7.3. Deployment Mode
- 20.7.4. Imaging Modality
- 20.7.5. Technology
- 20.7.6. Workflow Stage
- 20.7.7. Functionality
- 20.7.8. Clinical Setting
- 20.7.9. Application
- 20.7.10. End User
- 20.8. Rest of Africa Medical Imaging AI Market
- 20.8.1. Country Segmental Analysis
- 20.8.2. Component
- 20.8.3. Deployment Mode
- 20.8.4. Imaging Modality
- 20.8.5. Technology
- 20.8.6. Workflow Stage
- 20.8.7. Functionality
- 20.8.8. Clinical Setting
- 20.8.9. Application
- 20.8.10. End User
- 21. South America Medical Imaging AI Market Analysis
- 21.1. Key Segment Analysis
- 21.2. Regional Snapshot
- 21.3. South America Medical Imaging AI Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
- 21.3.1. Component
- 21.3.2. Deployment Mode
- 21.3.3. Imaging Modality
- 21.3.4. Technology
- 21.3.5. Workflow Stage
- 21.3.6. Functionality
- 21.3.7. Clinical Setting
- 21.3.8. Application
- 21.3.9. End User
- 21.3.10. Country
- 21.3.10.1. Brazil
- 21.3.10.2. Argentina
- 21.3.10.3. Rest of South America
- 21.4. Brazil Medical Imaging AI Market
- 21.4.1. Country Segmental Analysis
- 21.4.2. Component
- 21.4.3. Deployment Mode
- 21.4.4. Imaging Modality
- 21.4.5. Technology
- 21.4.6. Workflow Stage
- 21.4.7. Functionality
- 21.4.8. Clinical Setting
- 21.4.9. Application
- 21.4.10. End User
- 21.5. Argentina Medical Imaging AI Market
- 21.5.1. Country Segmental Analysis
- 21.5.2. Component
- 21.5.3. Deployment Mode
- 21.5.4. Imaging Modality
- 21.5.5. Technology
- 21.5.6. Workflow Stage
- 21.5.7. Functionality
- 21.5.8. Clinical Setting
- 21.5.9. Application
- 21.5.10. End User
- 21.6. Rest of South America Medical Imaging AI Market
- 21.6.1. Country Segmental Analysis
- 21.6.2. Component
- 21.6.3. Deployment Mode
- 21.6.4. Imaging Modality
- 21.6.5. Technology
- 21.6.6. Workflow Stage
- 21.6.7. Functionality
- 21.6.8. Clinical Setting
- 21.6.9. Application
- 21.6.10. End User
- 22. Key Players/ Company Profile
- 22.1. Aidoc
- 22.1.1. Company Details/ Overview
- 22.1.2. Company Financials
- 22.1.3. Key Customers and Competitors
- 22.1.4. Business/ Industry Portfolio
- 22.1.5. Product Portfolio/ Specification Details
- 22.1.6. Pricing Data
- 22.1.7. Strategic Overview
- 22.1.8. Recent Developments
- 22.2. Arterys, Inc.
- 22.3. Butterfly Network, Inc.
- 22.4. Canon Medical Systems Corporation
- 22.5. Digital Diagnostics Inc.
- 22.6. Enlitic, Inc.
- 22.7. GE HealthCare Technologies Inc.
- 22.8. Google LLC
- 22.9. HeartFlow, Inc.
- 22.10. iCAD, Inc.
- 22.11. Infervision
- 22.12. International Business Machines Corporation (IBM)
- 22.13. Koninklijke Philips N.V.
- 22.14. Lunit Inc.
- 22.15. Microsoft Corporation
- 22.16. Qure.ai
- 22.17. Siemens Healthineers AG
- 22.18. Tempus AI, Inc.
- 22.19. Viz.ai, Inc.
- 22.20. Zebra Medical Vision
- 22.21. Other Key Players
- 22.1. Aidoc
Note* - This is just tentative list of players. While providing the report, we will cover more number of players based on their revenue and share for each geography
Research Design
Our research design integrates both demand-side and supply-side analysis through a balanced combination of primary and secondary research methodologies. By utilizing both bottom-up and top-down approaches alongside rigorous data triangulation methods, we deliver robust market intelligence that supports strategic decision-making.
MarketGenics' comprehensive research design framework ensures the delivery of accurate, reliable, and actionable market intelligence. Through the integration of multiple research approaches, rigorous validation processes, and expert analysis, we provide our clients with the insights needed to make informed strategic decisions and capitalize on market opportunities.
MarketGenics leverages a dedicated industry panel of experts and a comprehensive suite of paid databases to effectively collect, consolidate, and analyze market intelligence.
Our approach has consistently proven to be reliable and effective in generating accurate market insights, identifying key industry trends, and uncovering emerging business opportunities.
Through both primary and secondary research, we capture and analyze critical company-level data such as manufacturing footprints, including technical centers, R&D facilities, sales offices, and headquarters.
Our expert panel further enhances our ability to estimate market size for specific brands based on validated field-level intelligence.
Our data mining techniques incorporate both parametric and non-parametric methods, allowing for structured data collection, sorting, processing, and cleaning.
Demand projections are derived from large-scale data sets analyzed through proprietary algorithms, culminating in robust and reliable market sizing.
Research Approach
The bottom-up approach builds market estimates by starting with the smallest addressable market units and systematically aggregating them to create comprehensive market size projections.
This method begins with specific, granular data points and builds upward to create the complete market landscape.
Customer Analysis → Segmental Analysis → Geographical Analysis
The top-down approach starts with the broadest possible market data and systematically narrows it down through a series of filters and assumptions to arrive at specific market segments or opportunities.
This method begins with the big picture and works downward to increasingly specific market slices.
TAM → SAM → SOM
Research Methods
Desk / Secondary Research
While analysing the market, we extensively study secondary sources, directories, and databases to identify and collect information useful for this technical, market-oriented, and commercial report. Secondary sources that we utilize are not only the public sources, but it is a combination of Open Source, Associations, Paid Databases, MG Repository & Knowledgebase, and others.
- Company websites, annual reports, financial reports, broker reports, and investor presentations
- National government documents, statistical databases and reports
- News articles, press releases and web-casts specific to the companies operating in the market, Magazines, reports, and others
- We gather information from commercial data sources for deriving company specific data such as segmental revenue, share for geography, product revenue, and others
- Internal and external proprietary databases (industry-specific), relevant patent, and regulatory databases
- Governing Bodies, Government Organizations
- Relevant Authorities, Country-specific Associations for Industries
We also employ the model mapping approach to estimate the product level market data through the players' product portfolio
Primary Research
Primary research/ interviews is vital in analyzing the market. Most of the cases involves paid primary interviews. Primary sources include primary interviews through e-mail interactions, telephonic interviews, surveys as well as face-to-face interviews with the different stakeholders across the value chain including several industry experts.
| Type of Respondents | Number of Primaries |
|---|---|
| Tier 2/3 Suppliers | ~20 |
| Tier 1 Suppliers | ~25 |
| End-users | ~25 |
| Industry Expert/ Panel/ Consultant | ~30 |
| Total | ~100 |
MG Knowledgebase
• Repository of industry blog, newsletter and case studies
• Online platform covering detailed market reports, and company profiles
Forecasting Factors and Models
Forecasting Factors
- Historical Trends – Past market patterns, cycles, and major events that shaped how markets behave over time. Understanding past trends helps predict future behavior.
- Industry Factors – Specific characteristics of the industry like structure, regulations, and innovation cycles that affect market dynamics.
- Macroeconomic Factors – Economic conditions like GDP growth, inflation, and employment rates that affect how much money people have to spend.
- Demographic Factors – Population characteristics like age, income, and location that determine who can buy your product.
- Technology Factors – How quickly people adopt new technology and how much technology infrastructure exists.
- Regulatory Factors – Government rules, laws, and policies that can help or restrict market growth.
- Competitive Factors – Analyzing competition structure such as degree of competition and bargaining power of buyers and suppliers.
Forecasting Models / Techniques
Multiple Regression Analysis
- Identify and quantify factors that drive market changes
- Statistical modeling to establish relationships between market drivers and outcomes
Time Series Analysis – Seasonal Patterns
- Understand regular cyclical patterns in market demand
- Advanced statistical techniques to separate trend, seasonal, and irregular components
Time Series Analysis – Trend Analysis
- Identify underlying market growth patterns and momentum
- Statistical analysis of historical data to project future trends
Expert Opinion – Expert Interviews
- Gather deep industry insights and contextual understanding
- In-depth interviews with key industry stakeholders
Multi-Scenario Development
- Prepare for uncertainty by modeling different possible futures
- Creating optimistic, pessimistic, and most likely scenarios
Time Series Analysis – Moving Averages
- Sophisticated forecasting for complex time series data
- Auto-regressive integrated moving average models with seasonal components
Econometric Models
- Apply economic theory to market forecasting
- Sophisticated economic models that account for market interactions
Expert Opinion – Delphi Method
- Harness collective wisdom of industry experts
- Structured, multi-round expert consultation process
Monte Carlo Simulation
- Quantify uncertainty and probability distributions
- Thousands of simulations with varying input parameters
Research Analysis
Our research framework is built upon the fundamental principle of validating market intelligence from both demand and supply perspectives. This dual-sided approach ensures comprehensive market understanding and reduces the risk of single-source bias.
Demand-Side Analysis: We understand end-user/application behavior, preferences, and market needs along with the penetration of the product for specific application.
Supply-Side Analysis: We estimate overall market revenue, analyze the segmental share along with industry capacity, competitive landscape, and market structure.
Validation & Evaluation
Data triangulation is a validation technique that uses multiple methods, sources, or perspectives to examine the same research question, thereby increasing the credibility and reliability of research findings. In market research, triangulation serves as a quality assurance mechanism that helps identify and minimize bias, validate assumptions, and ensure accuracy in market estimates.
- Data Source Triangulation – Using multiple data sources to examine the same phenomenon
- Methodological Triangulation – Using multiple research methods to study the same research question
- Investigator Triangulation – Using multiple researchers or analysts to examine the same data
- Theoretical Triangulation – Using multiple theoretical perspectives to interpret the same data
Custom Market Research Services
We will customise the research for you, in case the report listed above does not meet your requirements.
Get 10% Free Customisation